IP Library › Granted Patent US 12,186,755
Granted Patent B2
US 12,186,755 · App. 17/334,544 · Granted Jan 7, 2025

Multi-well separation apparatus and reagent delivery device

Inventors: Ning Chen (Richmond, CA); Robert Keith Shanahan (Carlsbad, CA); Dayu Teng (San Diego, CA); Daniel Joseph Braun (San Diego, CA)
Assignee: DrugArray, Inc.
B01L3/5085B01F31/441B01F31/85B01L3/527G01N33/5008B01F2101/23B01L2200/025B01L2200/028B01L2200/0689B01L2200/16B01L2300/0609B01L2300/0829B01L2300/0851B01L2400/0433G01N2500/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,186,755
App. No.
17/334,544
Filed
May 28, 2021
Granted
Jan 7, 2025
Kind
B2
Art Unit
1798
USPC
422/552
Abstract

Described herein are multi-well separation devices configured to allow a composition comprising a target agent to be separated into multiple wells, subdivided, recombined into a single well, and/or re-separated into the same or a different configuration of wells. Also described herein are reagent loading devices configured to simultaneously deliver one or more test agents to a plurality of volumes without having to individually deliver the test agents. Together, these devices allow high throughput parallel processes without repetitive pipetting or liquid handling robotics, though they may also be used separately. Also described herein are kits and systems for chemical or biological assays, as well as methods for using the multi-well separation devices and reagent loading devices described herein.

Claims (43)

1. A chemical or biological assay device, comprising:

a substrate;

a separation seal; and

a removable separation well structure,

wherein the removable separation well structure comprises a plurality of walls defining a plurality of openings,

wherein the separation seal forms a leak-proof seal between a proximal surface of the substrate and a distal surface of the removable separation well structure, and

wherein the substrate is coupled to the removable separation well structure via the separation seal to form a plurality of separation wells such that each separation well is isolated from other separation wells.

2. The device of claim 1 , further comprising:

a boundary wall, wherein a distal surface of the boundary wall is coupled to the proximal surface of the substrate to form a holding cavity.

3. The device of claim 2 , further comprising:

a boundary seal, wherein the boundary seal forms a leak-proof seal with the distal surface of the boundary wall and the proximal surface of the substrate,

wherein the boundary wall is coupled to the substrate via the boundary seal to form the holding cavity.

4. The device of claim 1 , further comprising:

a concentrating well structure located between the substrate and the removable separation well structure,

wherein the concentrating well structure comprises a plurality of openings, wherein each of the plurality of openings of said concentrating well structure corresponds to one of the plurality of openings defined by the removable separation well structure,

and wherein each of the plurality of openings of said concentrating well structure has a proximal end cross-sectional area and a distal end cross-sectional area, and wherein the proximal end cross-sectional area is greater than the distal end cross-sectional area.

5. The device of claim 3 , wherein the boundary seal is located between a substrate holder and the substrate.

6. A method of performing a chemical or biological assay using the device of claim 1 , comprising:

i) applying a target agent to the substrate;

ii) coupling the removable separation well structure to the substrate to form the plurality of separation wells, thereby dividing the target agent into a plurality of subpopulations, each subpopulation in one of the plurality of separation wells; and

iii) applying a plurality of test agents to the plurality of subpopulations,

wherein the effects of the plurality of test agents on the target agent are analyzed.

7. The method of claim 6 , wherein the target agent is cells in a cell suspension, and wherein the plurality of test agents is a plurality of drug.

8. The method of claim 7 , wherein applying the plurality of drugs to the plurality of subpopulations comprises simultaneously applying the plurality of drugs to the plurality of subpopulations using a reagent loading device comprising a plurality of protrusions.

9. The method of claim 6 , wherein the target agent is cells in a hydrogel, and wherein the plurality of test agents is a plurality of drugs.

10. The method of claim 9 , wherein applying the plurality of drugs to the plurality of subpopulations comprises simultaneously applying the plurality of drugs to the plurality of subpopulations.

11. A method of performing a chemical or biological assay using the device of claim 1 , comprising:

i) applying a cell suspension comprising cells to the substrate;

ii) coupling the removable separation well structure to the substrate to form the plurality of separation wells, thereby dividing the cells into a plurality of subpopulations, each subpopulation in one of the plurality of separation wells;

iii) uncoupling the removable separation well structure from the substrate;

iv) applying a drug to the substrate;

v) recoupling the removable separation well structure to the substrate, thereby re-dividing the cells into the plurality of subpopulations; and

vi) applying a plurality of primary antibodies to the plurality of subpopulations;

vii) applying a plurality of secondary antibodies to the plurality of subpopulations.

12. The method of claim 11 , wherein applying the plurality of primary antibodies to the plurality of subpopulations comprises simultaneously applying the plurality of primary antibodies to the plurality of subpopulations using a reagent loading device comprising a plurality of protrusions, and wherein applying the plurality of secondary antibodies to the plurality of subpopulations comprises simultaneously applying the plurality of secondary antibodies to the plurality of subpopulations using a reagent loading device comprising a plurality of protrusions.

13. The method of claim 12 , wherein the target agent is a drug, and wherein the plurality of test agents is a plurality of cell libraries.

14. The method of claim 13 , wherein applying the plurality of cell libraries to the plurality of subpopulations comprises simultaneously applying one of the plurality of cell libraries to each of the plurality of wells using a reagent loading device comprising a plurality of protrusions.

15. The device of claim 1 , wherein a separation well in the plurality of separation wells contains cells in a cell suspension.

16. The device of claim 1 , wherein the substrate is coated with a protein, a hydrogel, a polymer, a chemical compound, a fixed cell, or a micro-organism.

17. The device of claim 2 , wherein

the boundary wall comprises a substrate holder lock and a separation well lock, wherein the removable separation well structure comprises a separation well clip, wherein the separation well lock interfaces with the separation well clip;

and wherein the substrate holder is configured to couple the substrate to the boundary wall to form a holding cavity when coupled, wherein the substrate holder comprises a boundary wall clip configured to couple the substrate holder to the boundary wall, wherein the substrate holder lock interfaces with the boundary wall clip of the substrate holder, and wherein the removable separation well structure is coupled within the holding cavity.

18. The device of claim 17 , further comprising a concentrating well structure located between the substrate and the removable separation well structure.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 1, 2021
From: CHEN, NING; SHANAHAN, ROBERT KEITH; TENG, DAYU; BRAUN, DANIEL JOSEPH
To: DRUGARRAY, INC.
Reel/Frame 057668/0911 →
Continuity (3)
Division 15120057
Provisional Application 61941368 · Feb 18, 2014
Related Publication 20210283598A1 · Sep 16, 2021
References Cited (54)
US 3883398A · Ono · 1975 [cited by applicant]
US 4891321A · Hubscher · 1990 [cited by applicant]
US 4988618A · Li · 1991 [cited by applicant]
US 5219528A · Clark · 1993 [cited by examiner]
US 5882930A · Baier · 1999 [cited by applicant]
US 6027873A · Schellenberger · 2000 [cited by applicant]
US 6171555B1 · Cargill · 2001 [cited by applicant]
US 6592819B1 · Ogura · 2003 [cited by applicant]
US 7344877B1 · Camacho · 2008 [cited by applicant]
US 7736594B1 · Grudzien · 2010 [cited by applicant]
US 11090654B2 · Chen et al. · 2021 [cited by applicant]
US 20020094304A1 · Yang · 2002 [cited by applicant]
US 20030166263A1 · Haushalter · 2003 [cited by applicant]
US 20040037748A1 · Hasan · 2004 [cited by applicant]
US 20040037750A1 · Stimpson · 2004 [cited by applicant]
US 20040079580A1 · Manna · 2004 [cited by applicant]
US 20040137605A1 · Mcgarry · 2004 [cited by applicant]
US 20040226885A1 · Chen · 2004 [cited by applicant]
US 20060078463A1 · Shea · 2006 [cited by applicant]
US 20070280860A1 · Goodwin · 2007 [cited by applicant]
US 20080286161A1 · Heaney · 2008 [cited by applicant]
US 20100083778A1 · Bell · 2010 [cited by applicant]
US 20100151511A1 · Greenizen · 2010 [cited by applicant]
US 20170136456A1 · Chen · 2017 [cited by applicant]
CN 1239905 · 1999 [cited by applicant]
CN 101236203A · 2008 [cited by applicant]
CN 101472940A · 2009 [cited by applicant]
CN 101506643A · 2009 [cited by applicant]
CN 101529246 · 2009 [cited by applicant]
CN 102382765A · 2012 [cited by applicant]
JP 1201156A2 · 1989 [cited by applicant]
JP 2001099847A2 · 2001 [cited by applicant]
JP 2004340971A · 2004 [cited by applicant]
JP 2005509737A · 2005 [cited by applicant]
JP 2005536727T2 · 2005 [cited by applicant]
JP 2008200037A · 2008 [cited by applicant]
WO 199815356A1 · 1998 [cited by applicant]
WO 2003018854A2 · 2003 [cited by applicant]
WO 2003100421A1 · 2003 [cited by applicant]
WO 2004018104A1 · 2004 [cited by applicant]
WO 2005016532A2 · 2005 [cited by applicant]
WO 2005016532A3 · 2005 [cited by applicant]
WO 2008057111A2 · 2008 [cited by applicant]
WO 2009034927A1 · 2009 [cited by applicant]
WO 2008057111A3 · 2009 [cited by applicant]
WO 2011012859A1 · 2011 [cited by applicant]
WO 2015126979A1 · 2015 [cited by applicant]
European Communication Pursuant to Article 94(3): EPC, mailed on Oct. 19, 2021, for European Patent Application No. 20154686.8, filed Jan. 30, 2020, 5 pages. [cited by applicant]
European Examination Report mailed on Mar. 19, 2021, for European Application No. 20154686.8, filed on Jan. 30, 2020, 6 pages. [cited by applicant]
European Extended Search Report mailed on Sep. 29, 2017, for EP Application No. 15752342.4, filed on Sep. 8, 2016, fifteen pages. [cited by applicant]
Extended European Search Report, mailed on Jun. 16, 2020, for European Application No. 20154686.8, filed on Jan. 30, 2020, 13 pages. [cited by applicant]
International Preliminary Report on Patentability Sep. 1, 2016, for PCT Patent Application No. PCT/US2015/16435, Internationally filed on Feb. 18, 2015, eleven pages. [cited by applicant]
International Search Report mailed on Jul. 14, 2015, for PCT Patent Application No. PCT/US2015/16435, Internationally filed on Feb. 18, 2015, five pages. [cited by applicant]
Written Opinion mailed on Jul. 14, 2015, for PCT Patent Application No. PCT/US2015/16435, internationally filed on Feb. 18, 2015, twelve pages. [cited by applicant]
Cited By (4)
US 12,529,094 US 12,553,805 US 12,566,114 US 12,668,835